Clinical Trial Update: Pharmacokinetic Study of Oral Testosterone (T) Ester Formulations in Hypogonadal Men [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of oral testosterone ester formulations in men with hypogonadism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• oral testosterone ester formulations

Snippet

Sponsor: Clarus Therapeutics, Inc. | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2021-06-24